Related Experiment Video
Updated: Aug 18, 2025

Basophil Activation Test for Allergy Diagnosis
Published on: May 31, 2021
Chronic spontaneous urticaria guidelines: What is new?
Torsten Zuberbier1, Jonathan A Bernstein2, Marcus Maurer1
1Institute of Allergology, Charité - Universitätsmedizin Berlin; Fraunhofer Institute for Translational Medicine and Pharmacology, Allergology and Immunology, Berli.
This summary highlights the latest international urticaria guideline updates for managing acute or chronic urticaria (hives). It details changes impacting clinical practice for physicians and specialists.
Area of Science:
- Allergy and Clinical Immunology
- Dermatology
Background:
- Urticaria is a complex inflammatory condition characterized by wheals and/or angioedema.
- Recent advancements necessitate updated clinical guidelines for effective patient management.
Purpose of the Study:
- To present the newest international guideline for urticaria management.
- To highlight key changes from previous guidelines and their clinical implications.
Main Methods:
- Guideline development followed the Grading of Recommendations Assessment Development and Evaluation (GRADE) approach.
- Consensus recommendations were established through a Delphi conference involving over 250 international specialists.
- The guideline is endorsed by more than 50 international societies.
Main Results:
- The revised guideline offers updated definitions, classifications, diagnostic approaches, and management strategies for urticaria.
- Key changes aim to standardize and improve the care of patients with acute and chronic urticaria.
Conclusions:
- The updated international urticaria guideline provides crucial information for primary care physicians and specialists.
- Implementation of these revised recommendations is expected to enhance the clinical practice of urticaria management.
Related Concept Videos
Hypersensitivities
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Allergic Drug Reactions
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Allergic Reactions
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:

